These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 877939)
41. ACE inhibitors for all--'Hope' for the heart and failure for the kidneys? Goldsmith D J Hum Hypertens; 2001 Mar; 15(3):147-51. PubMed ID: 11317197 [No Abstract] [Full Text] [Related]
42. [The problem of the prophylaxis of bilirubin encephalopathy in the premature infant. Experiences with transfusions of human serum albumin]. Bassanetti F; Bovi I; Moretti M Lattante; 1965 Oct; 36(10):705-27. PubMed ID: 5861604 [No Abstract] [Full Text] [Related]
43. Antalgic properties of proxazole. Double blind study in visceral algoplastic conditions. De Gregorio M; Damiani S; Gatta G Panminerva Med; 1969 Sep; 11(9):436-40. PubMed ID: 4901029 [No Abstract] [Full Text] [Related]
44. Therapeutics bibliography for clinical pharmacists. Rosman AW Am J Hosp Pharm; 1980 Mar; 37(3):406-14 contd. PubMed ID: 6989237 [TBL] [Abstract][Full Text] [Related]
45. [Therapeutic properties of oxygen foam]. Zanozdra MS Fiziol Zh; 1966; 12(5):612-6. PubMed ID: 5990780 [No Abstract] [Full Text] [Related]
46. Experience with the transfusion of human albumin into patients with established liver damage. MARTIN NH Proc R Soc Med; 1954 Oct; 47(10):836-8. PubMed ID: 13215516 [No Abstract] [Full Text] [Related]
48. Assessment of new cardiovascular drugs. Relationships between considerations, professional characteristics, and prescribing. Wieringa NF; Denig P; de Graeff PA; Vos R Int J Technol Assess Health Care; 2001; 17(4):559-70. PubMed ID: 11758299 [TBL] [Abstract][Full Text] [Related]
50. [Methods of evaluating drug therapy, particularly in cardiovascular diseases]. Lövy O; Richter M; Cepelík J; Steiner A Cesk Zdrav; 1985 Jan; 33(1):34-42. PubMed ID: 3971461 [No Abstract] [Full Text] [Related]
51. [Automated billing and drug consumption recording in various health institutions in Prague]. Hovorová M; Spurný J Cesk Zdrav; 1970 Sep; 18(10):385-97. PubMed ID: 5457528 [No Abstract] [Full Text] [Related]
52. Nails in systemic disease. Daniel CR; Sams WM; Scher RK Dermatol Clin; 1985 Jul; 3(3):465-83. PubMed ID: 3830508 [TBL] [Abstract][Full Text] [Related]
53. [Analysis of our drug consumption in various so-called geriatrie diseases]. Krankemann G Dtsch Gesundheitsw; 1968 Oct; 23(41):1938-40. PubMed ID: 5712783 [No Abstract] [Full Text] [Related]
54. [Certain economical aspects of drug supply to the intensive care departments]. Ermakov VV; Troshina IM; Markova AI; Syrkin AL; Alekseeva VM Sov Med; 1975 Mar; (3):131-4. PubMed ID: 1154089 [No Abstract] [Full Text] [Related]
55. The relationship between plasma proteins and calcium in various diseases. Smarsz C; Adamski A Pol Med J; 1968; 7(2):358-64. PubMed ID: 5658051 [No Abstract] [Full Text] [Related]
56. [First clinical trails with the "medium tranquilizer" mesoridazine]. Rhomberg F; Staehelin B Schweiz Med Wochenschr; 1967 Apr; 97(16):521-5. PubMed ID: 4875573 [No Abstract] [Full Text] [Related]
57. Overuse of albumin. Hollander AG JAMA; 1980 Jan; 243(2):121. PubMed ID: 7350348 [No Abstract] [Full Text] [Related]
58. Clinical use of albumin. Caraceni P; Tufoni M; Bonavita ME Blood Transfus; 2013 Sep; 11 Suppl 4(Suppl 4):s18-25. PubMed ID: 24333308 [No Abstract] [Full Text] [Related]
59. Interventions to Decrease Albumin Utilization: Identifying What Works. Mead E; Halpern NA Crit Care Med; 2016 Jul; 44(7):1428-9. PubMed ID: 27309162 [No Abstract] [Full Text] [Related]
60. [Human serum albumin--utilization and hospital economics. Considerations related to documentation]. Nesbakken R Tidsskr Nor Laegeforen; 1977 Jun; 97(17-18):885-9. PubMed ID: 877939 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]